2-8-11 Audio Interview with Total Nutraceutical Solutions, Inc. (OTCBB: TNUS)

TNUS" src="http://www.smallcapvoice.com/tnus/logo.jpg" alt="Total Nutraceutical Solutions, Inc. TNUS" width="151" height="75" />

Marvin S. Hausman M.D., CEO of Total Nutraceutical Solutions, Inc. TNUS called into to explain how TNS has formulated Ergo-D Traum(TM), a proprietary mushroom-phytonutrient formulation, and has filed a Provisional Use Patent entitled: “Anti-Inflammatory Approach to Prevention and Suppression of Post-Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), Depression and Associated Disease States.” This patent application describes how this novel dietary supplement formulation can be used for the prevention and control of inflammation and oxidative stress associated with a variety of medical conditions, including PTSD, TBI and chronic depression. A composition providing a phytonutrient and enriched mushrooms having enhanced vitamin D and Ergothioneine are disclosed.

TNS, a global biotechnology leader in whole food mushroom research and development focuses on discovering, formulating and marketing products composed primarily of organic, natural whole mushroom foods containing bioactive nutrients such as L-Ergothioneine and vitamin D, with potential health benefits. Our scientific strategy is to specialize in the development of production and analytic technologies for food and nutritional supplements mainly composed of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to our novel preventative health care formulations and nutritional approaches for a wide variety of human conditions and illnesses, we are also involved in the development, acquisition and ownership of breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.